Drug information for SOLIFENACIN SUCCINATE
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
TABLET; ORAL
10MG
Tentative Approval
SOLIFENACIN SUCCINATE
solifenacin succinate
TEVA PHARMS USA
91464
TABLET; ORAL
5MG
Tentative Approval
SOLIFENACIN SUCCINATE
solifenacin succinate
TEVA PHARMS USA
"
Drug Adverse Effects information for SOLIFENACIN SUCCINATE
Role code
Indications
Reaction
# Reports
PS
HYPERTONIC BLADDER
CHEST DISCOMFORT
1
PS
HYPERTONIC BLADDER
DIZZINESS
1
PS
HYPERTONIC BLADDER
DYSPNOEA
1
PS
URINARY INCONTINENCE
TRANSITIONAL CELL CARCINOMA
1
SS
HERPES ZOSTER OPHTHALMIC
NEUROTOXICITY
1
C
ABSCESS
ANAPHYLACTIC REACTION
1
C
ACUTE PSYCHOSIS
ALCOHOL ABUSE
1
C
ACUTE PSYCHOSIS
BLOOD ALCOHOL INCREASED
1
C
ACUTE PSYCHOSIS
DRUG INEFFECTIVE
2
C
ACUTE PSYCHOSIS
SCHIZOPHRENIA, PARANOID TYPE
2
C
ACUTE PSYCHOSIS
SINUS TACHYCARDIA
2
C
ACUTE PSYCHOSIS
URINARY TRACT INFECTION
2
C
ACUTE PSYCHOSIS
WHITE BLOOD CELL COUNT INCREASED
2
C
AGE-RELATED MACULAR DEGENERATION
TRANSIENT ISCHAEMIC ATTACK
1
C
BACK PAIN
ALCOHOL ABUSE
1
C
BACK PAIN
BLOOD ALCOHOL INCREASED
1
C
BACK PAIN
DRUG INEFFECTIVE
2
C
BACK PAIN
SCHIZOPHRENIA, PARANOID TYPE
2
C
BACK PAIN
SINUS TACHYCARDIA
2
C
BACK PAIN
URINARY TRACT INFECTION
2
C
BACK PAIN
WHITE BLOOD CELL COUNT INCREASED
2
C
BLOOD CALCIUM DECREASED
MALAISE
2
C
BLOOD CALCIUM DECREASED
NEUTROPENIA
2
C
BLOOD CALCIUM DECREASED
NEUTROPHIL COUNT DECREASED
2
C
BLOOD CALCIUM DECREASED
NEUTROPHIL COUNT INCREASED
2
C
BLOOD CALCIUM DECREASED
ORAL HERPES
2
C
BLOOD CALCIUM DECREASED
PYREXIA
2
C
BLOOD CALCIUM DECREASED
WHITE BLOOD CELL COUNT DECREASED
2
C
BLOOD CHOLESTEROL INCREASED
HYPERHIDROSIS
1
C
BLOOD CHOLESTEROL INCREASED
MYALGIA
1
C
CATAPLEXY
ATRIAL FIBRILLATION
1
C
CATAPLEXY
PALPITATIONS
1
C
CONSTIPATION
MALAISE
2
C
CONSTIPATION
NEUTROPENIA
2
C
CONSTIPATION
NEUTROPHIL COUNT DECREASED
2
C
CONSTIPATION
NEUTROPHIL COUNT INCREASED
2
C
CONSTIPATION
ORAL HERPES
2
C
CONSTIPATION
PYREXIA
2
C
CONSTIPATION
WHITE BLOOD CELL COUNT DECREASED
2
C
CYSTITIS INTERSTITIAL
ALOPECIA
1
C
CYSTITIS INTERSTITIAL
OFF LABEL USE
1
C
CYSTITIS INTERSTITIAL
SKIN BURNING SENSATION
1
C
CYSTITIS INTERSTITIAL
VISION BLURRED
1
C
DEPRESSION
MALAISE
2
C
DEPRESSION
NEUTROPENIA
2
C
DEPRESSION
NEUTROPHIL COUNT DECREASED
2
C
DEPRESSION
NEUTROPHIL COUNT INCREASED
2
C
DEPRESSION
ORAL HERPES
2
C
DEPRESSION
PYREXIA
2
C
DEPRESSION
WHITE BLOOD CELL COUNT DECREASED
2
C
DIABETES MELLITUS
MALAISE
2
C
DIABETES MELLITUS
NEUTROPENIA
2
C
DIABETES MELLITUS
NEUTROPHIL COUNT DECREASED
2
C
DIABETES MELLITUS
NEUTROPHIL COUNT INCREASED
2
C
DIABETES MELLITUS
ORAL HERPES
2
C
DIABETES MELLITUS
PYREXIA
2
C
DIABETES MELLITUS
WHITE BLOOD CELL COUNT DECREASED
2
C
GENERAL PHYSICAL CONDITION
ALCOHOL ABUSE
5
C
GENERAL PHYSICAL CONDITION
BLOOD ALCOHOL INCREASED
5
C
GENERAL PHYSICAL CONDITION
DRUG INEFFECTIVE
10
C
GENERAL PHYSICAL CONDITION
SCHIZOPHRENIA, PARANOID TYPE
10
C
GENERAL PHYSICAL CONDITION
SINUS TACHYCARDIA
10
C
GENERAL PHYSICAL CONDITION
URINARY TRACT INFECTION
10
C
GENERAL PHYSICAL CONDITION
WHITE BLOOD CELL COUNT INCREASED
10
C
HEPATO-LENTICULAR DEGENERATION
GASTROINTESTINAL HAEMORRHAGE
1
C
HERPES ZOSTER OPHTHALMIC
AGITATION
4
C
HERPES ZOSTER OPHTHALMIC
ANAPHYLACTIC REACTION
1
C
HERPES ZOSTER OPHTHALMIC
BLISTER
2
C
HERPES ZOSTER OPHTHALMIC
BLOOD CREATININE INCREASED
3
C
HERPES ZOSTER OPHTHALMIC
BLOOD POTASSIUM INCREASED
2
C
HERPES ZOSTER OPHTHALMIC
BLOOD PRESSURE INCREASED
2
C
HERPES ZOSTER OPHTHALMIC
BLOOD PRESSURE SYSTOLIC INCREASED
2
C
HERPES ZOSTER OPHTHALMIC
BLOOD SODIUM DECREASED
4
C
HERPES ZOSTER OPHTHALMIC
BLOOD UREA INCREASED
3
C
HERPES ZOSTER OPHTHALMIC
CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE
1
C
HERPES ZOSTER OPHTHALMIC
CONFUSIONAL STATE
4
C
HERPES ZOSTER OPHTHALMIC
CREATININE RENAL CLEARANCE DECREASED
2
C
HERPES ZOSTER OPHTHALMIC
DISORIENTATION
3
C
HERPES ZOSTER OPHTHALMIC
DRUG INTOLERANCE
1
C
HERPES ZOSTER OPHTHALMIC
EXFOLIATIVE RASH
1
C
HERPES ZOSTER OPHTHALMIC
EYE DISCHARGE
1
C
HERPES ZOSTER OPHTHALMIC
EYE SWELLING
2
C
HERPES ZOSTER OPHTHALMIC
HALLUCINATION, VISUAL
4
C
HERPES ZOSTER OPHTHALMIC
INCORRECT DOSE ADMINISTERED
1
C
HERPES ZOSTER OPHTHALMIC
MENTAL STATUS CHANGES
4
C
HERPES ZOSTER OPHTHALMIC
NEUROTOXICITY
3
C
HERPES ZOSTER OPHTHALMIC
PERIORBITAL OEDEMA
2
C
HERPES ZOSTER OPHTHALMIC
RASH ERYTHEMATOUS
2
C
HERPES ZOSTER OPHTHALMIC
RESPIRATORY RATE INCREASED
1
C
HERPES ZOSTER OPHTHALMIC
RHONCHI
3
C
HERPES ZOSTER OPHTHALMIC
SKIN EXFOLIATION
1
C
HERPES ZOSTER OPHTHALMIC
VISION BLURRED
3
C
HYPERSENSITIVITY
MALAISE
2
C
HYPERSENSITIVITY
NEUTROPENIA
2
C
HYPERSENSITIVITY
NEUTROPHIL COUNT DECREASED
2
C
HYPERSENSITIVITY
NEUTROPHIL COUNT INCREASED
2
C
HYPERSENSITIVITY
ORAL HERPES
2
C
HYPERSENSITIVITY
PYREXIA
2
C
HYPERSENSITIVITY
WHITE BLOOD CELL COUNT DECREASED
2
C
HYPERTHYROIDISM
MALAISE
2
C
HYPERTHYROIDISM
NEUTROPENIA
2
C
HYPERTHYROIDISM
NEUTROPHIL COUNT DECREASED
2
C
HYPERTHYROIDISM
NEUTROPHIL COUNT INCREASED
2
C
HYPERTHYROIDISM
ORAL HERPES
2
C
HYPERTHYROIDISM
PYREXIA
2
C
HYPERTHYROIDISM
WHITE BLOOD CELL COUNT DECREASED
2
C
HYPERTONIC BLADDER
ALOPECIA
2
C
HYPERTONIC BLADDER
OFF LABEL USE
1
C
HYPERTONIC BLADDER
SKIN BURNING SENSATION
2
C
HYPERTONIC BLADDER
VISION BLURRED
2
C
MULTIPLE SCLEROSIS
ERYTHEMA
2
C
MULTIPLE SCLEROSIS
HYPERSENSITIVITY
2
C
MULTIPLE SCLEROSIS
RASH
2
C
MULTIPLE SCLEROSIS
SWELLING
2
C
PRODUCT USED FOR UNKNOWN INDICATION
ANAPHYLACTIC REACTION
6
C
PRODUCT USED FOR UNKNOWN INDICATION
BRONCHITIS
11
C
PRODUCT USED FOR UNKNOWN INDICATION
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
11
C
PRODUCT USED FOR UNKNOWN INDICATION
CUTANEOUS VASCULITIS
18
C
PRODUCT USED FOR UNKNOWN INDICATION
HYPERSENSITIVITY
3
C
PRODUCT USED FOR UNKNOWN INDICATION
INJECTION SITE HAEMATOMA
5
C
PRODUCT USED FOR UNKNOWN INDICATION
VASCULITIC RASH
27
C
RESPIRATORY TRACT INFECTION
ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC
2
C
RESPIRATORY TRACT INFECTION
ASPIRATION
2
C
RESPIRATORY TRACT INFECTION
COMPLETED SUICIDE
2
C
RESPIRATORY TRACT INFECTION
MALAISE
2
C
RESPIRATORY TRACT INFECTION
OVERDOSE
2
C
RESPIRATORY TRACT INFECTION
RESPIRATORY TRACT INFECTION
2
C
RESPIRATORY TRACT INFECTION
TOXICITY TO VARIOUS AGENTS
2
C
RHEUMATOID ARTHRITIS
BRONCHITIS
3
C
RHEUMATOID ARTHRITIS
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
3
C
SCHIZOPHRENIA
ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC
4
C
SCHIZOPHRENIA
ASPIRATION
4
C
SCHIZOPHRENIA
COMPLETED SUICIDE
2
C
SCHIZOPHRENIA
MALAISE
6
C
SCHIZOPHRENIA
NEUTROPENIA
2
C
SCHIZOPHRENIA
NEUTROPHIL COUNT DECREASED
2
C
SCHIZOPHRENIA
NEUTROPHIL COUNT INCREASED
2
C
SCHIZOPHRENIA
ORAL HERPES
2
C
SCHIZOPHRENIA
OVERDOSE
3
C
SCHIZOPHRENIA
PYREXIA
2
C
SCHIZOPHRENIA
RESPIRATORY TRACT INFECTION
4
C
SCHIZOPHRENIA
TOXICITY TO VARIOUS AGENTS
2
C
SCHIZOPHRENIA
WHITE BLOOD CELL COUNT DECREASED
2
C
SKIN INFECTION
MALAISE
8
C
SKIN INFECTION
NEUTROPENIA
8
C
SKIN INFECTION
NEUTROPHIL COUNT DECREASED
8
C
SKIN INFECTION
NEUTROPHIL COUNT INCREASED
8
C
SKIN INFECTION
ORAL HERPES
8
C
SKIN INFECTION
PYREXIA
8
C
SKIN INFECTION
WHITE BLOOD CELL COUNT DECREASED
8
C
SMOKING CESSATION THERAPY
HYPERSENSITIVITY
1
Ads by Google